Titanium-Based Nanoarchitectures for Sonodynamic Therapy-Involved Multimodal Treatments

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Sonodynamic therapy (SDT) utilizes ultrasound and sonosensitizers to generate reactive oxygen species (ROS) for therapeutic applications.
• Nanotechnology has enabled the development of advanced sonosensitizers, particularly titanium-based nanomaterials, due to their favorable properties.

Purpose of the Study:

• To review recent advancements in cancer therapy and tissue engineering using titanium nanoplatforms in SDT.
• To discuss synthesis strategies and biosafety of titanium-based nanoplatforms for SDT.
• To highlight challenges and future prospects for clinical translation.

Main Methods:

• Literature review of studies on titanium nanoplatforms for SDT.
• Analysis of synthesis methods and biosafety data.
• Discussion of integrated therapeutic approaches and clinical potential.

Main Results:

• Titanium-based nanomaterials show high biocompatibility, catalytic efficiency, and tunable properties for SDT.
• These nanoplatforms facilitate the combination of SDT with other therapies like chemotherapy and immunotherapy.
• Recent developments show promise in cancer treatment and tissue engineering applications.

Conclusions:

• Titanium nanoplatforms offer a promising avenue for noninvasive cancer therapy and tissue engineering via SDT.
• Further research into synthesis, biosafety, and clinical translation is crucial for realizing their full potential.